Navigation Links
Monkeys Respond To HIV Treatment

US based researchers are reported to identified two drugs meant for treating HIV patients also served to protect monkeys from contracting the AIDS virus. // As to whether the same can be applied to human beings also has not yet been confirmed, even though it may be possible.

Rhesus monkeys were experimented upon by the Centers for Disease and Prevention’s Dr. Walid Heneine, through injecting them with a version of the Truvada, manufactured by Gilead Sciences. This pill is a combination of Emtriva, or emtracitibine and Viread, or tenofovir. The combination has not yet cured a human being from the HIV infection, even though it helps in maintaining the existing state of health. After the injection, the monkeys were exposed continuously for 14 days to SHIV, a human-monkey AIDS virus.

Injections were also administered on a daily basis to the six experimental animals. None of the animals contracted the AIDS virus. There is a possibility that potent antiretrovirals administered before being exposed to HIV may protect a human being from AIDS, according to the results of the experiment, even though this may only be for a temporary period. The HIV virus is reported to be wrecking devastation among developing nations.

The US President has however recommended abstinence as the best way of stopping the disease, while those in the medical field have called for more practical methods to halt the spread of the disease. Even among the HIV virus, the A clade variety is reported to be less deadly than the D type, which brought about death more rapidly. There are a total 40 million people in this world who are HIV positive, and the developing world, particularly Africa accounts for most of this.
'"/>




Page: 1

Related medicine news :

1. Monkeys offer genetic clues to adult blindness
2. Urban Monkeys Source Of Virus Infections
3. Drug Company Admits Knowledge Of Side Effects In Monkeys
4. HIV Vaccine for Monkeys Increases Survival Rates
5. Effectiveness of Potential Bird flu Vaccine to be Tested on Monkeys
6. Acute Gastroenteritis Responds To Treatment With Either Gatorade Or Pedialyte
7. Study Highlights How Bacteria Respond To Changes In Environment
8. Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat
9. Immigrants Who Responded After 9/11 Lack Health Care
10. Responders On 9/11 Face Health Risks
11. Stubborn Ulcerative Colitis Responds to Arthritis Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: